Brevan Howard Capital Management »

Eliem Therapeutics shares owned by Brevan Howard Capital Management

Quarter-by-quarter ownership of Eliem Therapeutics (CLYM) shares owned by Brevan Howard Capital Management from 13F filings

Historical chart of Brevan Howard Capital Management investment in Eliem Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Eliem Therapeutics held by Brevan Howard Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Eliem Therapeutics by Brevan Howard Capital Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $388k 57k 6.85

More positions owned by Brevan Howard Capital Management

Ishares Bitcoin Trust Etf Shs Ben Int (IBIT)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Ishares Tr Iboxx Hi Yd Etf (HYG)
Ishares Tr 20 Yr Tr Bd Etf (TLT)
Ishares Tr Iboxx Inv Cp Etf (LQD)
NVIDIA Corporation (NVDA)
Tesla Motors (TSLA)
Pdd Holdings Sponsored Ads (PDD)
Ishares Tr China Lg-cap Etf (FXI)
Spdr Gold Tr Gold Shs (GLD)
Select Sector Spdr Tr State Street Fin (XLF)
Agnc Invt Corp Com reit (AGNC)
Ishares Msci Brazil Etf (EWZ)
Meta Platforms Cl A (META)
Palantir Technologies Cl A (PLTR)

View all positions for Brevan Howard Capital Management

Top funds holding Eliem Therapeutics

RA Capital Management
MPM Oncology Impact Management
Braidwell
Vanguard Group
Dr. Jeffrey R. Jay, M.D.
Affinity Asset Advisors
Millennium Management
Vanguard Capital Management
Kynam Capital Management
Driehaus Capital Management
ADAR1 Capital Management
Susquehanna International
Nan Fung Trinity
Sphera Funds Management
BlackRock

View all funds holding Eliem Therapeutics